e.g. mhealth
Search Results (1 to 5 of 5 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 2 JMIR Research Protocols
- 1 JMIR Aging
- 1 JMIR Rehabilitation and Assistive Technologies
- 1 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Human Factors
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR mHealth and uHealth
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Cardio
- 0 JMIR Formative Research
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
An early national survey in urban China indicated that 21% of men and 35% of women aged 20‐64 years had at least one persistent sexual dysfunction, with lack of sex interest, erectile difficulties (men), and inability to reach orgasm being the most common problems [9]. There are substantial variations in the prevalence of sexual response problems across different global regions, with noticeable differences between men and women.
JMIR Aging 2025;8:e66772
Download Citation: END BibTex RIS
In the context of 131 I-therapy for thyroid cancer, few studies have assessed the long-term quality of life at 6 months or later after 131 I-therapy [8-12], whereas it has been shown that salivary dysfunction assessed by a specific questionnaire may occur more than 6 months after therapy for 25% of patients [13].
JMIR Res Protoc 2022;11(7):e35565
Download Citation: END BibTex RIS
Remote Assessments of Hand Function in Neurological Disorders: Systematic Review
Reference 47: Markers for upper limb dysfunction in Amyotrophic Lateral Sclerosis using analysis of typingdysfunction
JMIR Rehabil Assist Technol 2022;9(1):e33157
Download Citation: END BibTex RIS
However, at least 10% of patients with SARS-Co V-2 infection will experience persistent and chronic olfactory dysfunction such as diminished smell (hyposmia) or the loss of smell (anosmia), which have been shown to result in a decreased quality of life, depressive symptoms, and nutrition issues [4-6]. One treatment option that is recommended for persistent olfactory dysfunction is daily olfactory training involving high-concentration aromatic oils [7].
J Med Internet Res 2021;23(5):e29583
Download Citation: END BibTex RIS
A recent systematic review and meta-analysis of studies investigating loss of smell and/or taste with COVID-19 infection reported a pooled prevalence of 52.7% and 43.9% for olfactory and gustatory dysfunction, respectively [14]. Also, Hopkins et al [15] found that 1 in 6 patients reported new onset anosmia as an isolated symptom. The onset of smell and/or taste loss is often abrupt and, unlike other upper respiratory tract infections, it often occurs in the absence of nasal obstruction [13,16].
JMIR Res Protoc 2020;9(12):e24797
Download Citation: END BibTex RIS